MediPharm Labs Corp. (MEDIF)
- Previous Close
0.0597 - Open
0.0600 - Bid --
- Ask --
- Day's Range
0.0575 - 0.0630 - 52 Week Range
0.0400 - 0.0770 - Volume
29,294 - Avg. Volume
98,615 - Market Cap (intraday)
25.455M - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Mar 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
www.medipharmlabs.com166
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: MEDIF
Performance Overview: MEDIF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDIF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDIF
Valuation Measures
Market Cap
23.66M
Enterprise Value
12.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.95
Price/Book (mrq)
0.66
Enterprise Value/Revenue
0.37
Enterprise Value/EBITDA
-1.16
Financial Highlights
Profitability and Income Statement
Profit Margin
-39.57%
Return on Assets (ttm)
-12.01%
Return on Equity (ttm)
-24.00%
Revenue (ttm)
33.06M
Net Income Avi to Common (ttm)
-13.08M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
18.25M
Total Debt/Equity (mrq)
4.33%
Levered Free Cash Flow (ttm)
-95.75k
Company Insights: MEDIF
MEDIF does not have Company Insights